Organization in Special Consultative
Status with UN ECOSOC

2016 World Alliance Forumin San Francisco
US-Japan Innovative HealthcareTechnologies Conference

San Francisco, California, USA | November 21 & 22, 2016

US-Japan Innovative Healthcare Technologies Conference
Since 2013, the World Alliance Forum in San Francisco (WAFSF) has focused on advancing regenerative
medicine. In the past three years, a total of more than one thousand leaders from the US, Japan, andother countries, representing diverse companies from different industries, academic and research
institutions, governments, and nonprofit organizations were in attendance. As a result of this premier,annual international conference, multiple partnerships and countless connections were formed.
This year, WAFSF attempts to broaden its impact by expanding the focus into other novel healthcaretechnologies. In particular, the commercialization and industrialization of healthcare IoT & digital health,gene therapy and cancer immunotherapy, and regenerative medicine are the Forum’s central theme.
Immersion in the active discussions by leading visionaries and unique attendee composition at WAFSF
encourages cross-industry, cross-sector, and cross-boarder collaborations, which makes WAFSF animportant destination for business development.

On the Agenda
The Digital Revolution – also known as the Third Industrial Revolution – was brought about in the late twentiethcentury by the integration of computing and communication technologies, which gave birth to the IT industry. The
convergence of IT and healthcare technologies have become more and more prominent and will develop into theengine of many new businesses in the field of digital health and healthcare IoT.
While digital health makes healthcare more effective by personalizing it,
remarkable biotechnology breakthroughs such as new gene-editing andstem-cell innovations are at the forefront of advanced healthcaretechnologies and are enabling the personalization of medicine.
This year’s WAFSF will focus on this paradigm shift of healthcare’s
personalization by examining these advanced healthcare technologies:
digital health/healthcare IoT, gene therapy and cancer immunotherapy,
and regenerative medicine. The Forum will highlight trends, visions andstrategies towards commercialization, and showcase projects andbusinesses.

Genomics Big
Data, Smart
Implants, Care
Robots, etc.

Healthcare
IoT/DigitalHealthGene Therapy& Cancer
Immunotherapy

AdvancedHealthcareTechnologies

Regenerative
Medicine

ZFN, TALEN,CRISPR/Cas9,CAR-T, etc.

iPS Cells,
Cell Sheets,
Cell Banking,Endogenous reg.
med., etc.

Forum Feature
Distinguished Speakers

High Quality Networking

Every year, WAFSF is proud tohost the world’s leading figuresand visionaries in the field. On thepicture are Nobel laureates Dr.
Shinya Yamanaka (left) and Dr.
Paul Berg (right) at 2013 WAFSF.

Attendees represent different
industries, research institutions, andgovernmental agencies. This
unique composition of attendees
make way for new ideas and haveresulted in multiple collaborationand partnership deals.

Business Opportunities

Compelling Agenda

Many business opportunities areoffered at WAFSF, ranging fromsponsorships, exhibitions, andpresentations, which give directaccess to key decision makers
from the industry, academia, andgovernments.

From trending innovations andstartups and funding andcommercialization strategies to new
regulatory frameworks, discussions
at WAFSF are active, exciting,comprehensive, andinterdisciplinary.

Monday, November 21

Tuesday, November 22

AM

Innovative Healthcare Technologies
Overview & Update

AM

Gene Therapy
Cancer Immunotherapy

PMHealthcare IoTDigital HealthPM

Regenerative
Medicine

Speakers (Selected, 2013-2015)

ShinyaYamanaka(Kyoto U.)

PaulBerg(Stanford U.)

MasayoTakahashi(RIKEN)

IrvingWeissman(Stanford U.)

EdwardLanphier(Sangamo)

RobertKlein(CIRM)

SusanSolomon(NYSCF)

Hideyuki
Okano(Keio U.)

GeorgeHara(DEFTA)

JonathanThomas(CIRM)Yuzo
Toda(FIRM)

Perry
Karsen(Celgene)

Yoshiki
Sawa(Osaka U.)

Brock
Reeve
(Harvard U.)

Seigo
Izumo
(Takeda)Amy
DuRoss(GE Ventures)Attendee Background50%+ Business, 20% Academic, 10% Government
Just over half of the participants represent businesses. Of the businessparticipants, about 50% are from large or public corporations, and the other halffrom startups, small and medium companies.

90% Decision Makers
Out of the business participants, about 40% are key decision
makers – chairpersons, presidents, board directors, CEOs orother C-level officers. Another 50% hold middle management
positions.

Gov’t

1,000+ Since 2013
Since 2013, more than 1,000 people have attended WAFSF. Participants comefrom the United States, Japan, China, Korea, Canada, Israel, Sweden, andseveral other countries.

Governmental Agencies, Industry Groups, Media…
Regulatory, policy-making, and funding officials are in attendance as well as manyindustry and nonprofit groups such as ARM, FIRM, and NYSCF. WAFSF is covered bymedia outlets, including Cell Stem Cell, BioCentury, NHK, Forbes Japan, etc.

Details & Summary
Event2016 World Alliance Forum in San Francisco:
US-Japan Innovative Healthcare Technologies Conference

Dates

Monday, November 21, 2016 &Tuesday, November 22, 2016

Venue

Golden Gate Club, San Francisco, California, USA

Organizer

Alliance Forum Foundation (AFF) www.allianceforum.org

Objectives

Support the commercialization and industrialization of technological innovations in healthcare byencouraging cross-industry, cross-boarder, cross-sector collaboration

FeeEarly Bird Registration: $500, General Admission: $800**Academic & Students discounts are available. Additional costs may apply.

Registration & Information
Visit WAFSF website to see the latest news,
updated agenda and speaker information, andto register.

www.wafsf.org
For questions or businessinquiries, please email:opportunity

programs@allianceforum.org